跳至主要内容
临床试验/NCT00758667
NCT00758667终止不适用

Chemically Assisted Capsulectomy-A New Clinical Approach

Vanderbilt University0 个研究点目标入组 20 人开始时间: 2005年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
20
主要终点
Compare Number of Patients With Capsular Contracture in Mesna Group vs Standard of Care

研究概览

简要总结

The purpose of this study is to make available an agent,Mesna, which can assist the surgeon during the procedure of capsulectomy.

详细描述

Mesna is a FDA approved drug for the treatment of respiratory diseases and is used a protective agent against drugs in oncology patients. It has also been used in Gynecologic surgery and ENT. Mesna is a drug that breaks down adhesions between tissue layers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • All females undergoing capsulectomy

排除标准

  • All pregnant women and nursing mothers will be exclued

研究组 & 干预措施

Use of Mesna

Experimental

Standard surgical procedure with Mesna

干预措施: Mesna (Drug)

结局指标

主要结局

Compare Number of Patients With Capsular Contracture in Mesna Group vs Standard of Care

时间窗: one year

次要结局

  • Compare Number of Patients With Adverse Events in the Mesna Group vs the Standard of Care(one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

R. Bruce Shack

R. Bruce Shack, MD

Vanderbilt University

相似试验